Developer of wound healing products for chronic wounds. The company wound healing products provides a sterile disposable suspension for topical application in the treatment of chronic wounds such as skin ulcers, burns, trauma and post-surgery wounds.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 09-Nov-2010 | $200M | 0000 | 00000 | Completed | Generating Revenue |
3. Later Stage VC | 000 | 0000 | Completed | |||
2. Later Stage VC | 13-Dec-2007 | $1M | $10M | Completed | Clinical Trials - General | |
1. Early Stage VC | $9M | $9M | Completed |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
ES-2748805-T3 | Improved wound healing compositions comprising microspheres | Active | 13-Sep-2012 | 0000000000 | |
CA-2883455-A1 | Improved wound healing compositions comprising microspheres | Granted | 13-Sep-2012 | 0000000000 | |
CA-2883455-C | Improved wound healing compositions comprising microspheres | Active | 13-Sep-2012 | 0000000000 | |
US-9370533-B2 | Wound healing compositions comprising microspheres | Active | 13-Sep-2012 | 0000000000 | 0 |
US-20150231170-A1 | Wound healing compositions comprising microspheres | Granted | 13-Sep-2012 | A61K31/745 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Yuval Zuk | Chief Executive Officer |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Clal Biotechnology Industries | Venture Capital | Minority | 000 0000 | 000000 0 | |
Koonras Technologies | Corporation | Minority | 000 0000 | 000000 0 | |
LN Technology Innovations | Corporation | Minority | 000 0000 | 000000 0 | |
Technorov Holdings | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
The Challenge Fund - Etgar | Venture Capital | Minority | 000 0000 | 000000 0 |